These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7501233)

  • 21. Initiation and propagation stages of beta-amyloid are associated with distinctive apolipoprotein E, age, and gender profiles.
    Johnson JK; McCleary R; Oshita MH; Cotman CW
    Brain Res; 1998 Jul; 798(1-2):18-24. PubMed ID: 9666062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation.
    Lemere CA; Blusztajn JK; Yamaguchi H; Wisniewski T; Saido TC; Selkoe DJ
    Neurobiol Dis; 1996 Feb; 3(1):16-32. PubMed ID: 9173910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased apolipoprotein E epsilon 4 in epilepsy with senile plaques.
    Gouras GK; Relkin NR; Sweeney D; Munoz DG; Mackenzie IR; Gandy S
    Ann Neurol; 1997 Mar; 41(3):402-4. PubMed ID: 9066363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic and host factors for dementia in Down's syndrome.
    Schupf N; Sergievsky GH
    Br J Psychiatry; 2002 May; 180():405-10. PubMed ID: 11983636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microglial cells and amyloid beta protein (A beta) deposition; association with A beta 40-containing plaques.
    Mann DM; Iwatsubo T; Fukumoto H; Ihara Y; Odaka A; Suzuki N
    Acta Neuropathol; 1995; 90(5):472-7. PubMed ID: 8560980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alzheimer beta amyloid deposition enhanced by apoE epsilon4 gene precedes neurofibrillary pathology in the frontal association cortex of nondemented senior subjects.
    Yamaguchi H; Sugihara S; Ogawa A; Oshima N; Ihara Y
    J Neuropathol Exp Neurol; 2001 Jul; 60(7):731-9. PubMed ID: 11444802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lower frequency of apolipoprotein E4 allele in an "elderly" Down's syndrome population.
    Cosgrave M; Tyrrell J; Dreja H; Hawi Z; Lawlor BA; Gill M
    Biol Psychiatry; 1996 Oct; 40(8):811-3. PubMed ID: 8894078
    [No Abstract]   [Full Text] [Related]  

  • 28. Sequestration of amyloid beta-peptide.
    Goldgaber D; Schwarzman AI; Bhasin R; Gregori L; Schmechel D; Saunders AM; Roses AD; Strittmatter WJ
    Ann N Y Acad Sci; 1993 Sep; 695():139-43. PubMed ID: 8239272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A case-control study of apolipoprotein E genotypes in Alzheimer's disease associated with Down's syndrome. Dutch Study Group on Down's Syndrome and Ageing.
    van Gool WA; Evenhuis HM; van Duijn CM
    Ann Neurol; 1995 Aug; 38(2):225-30. PubMed ID: 7654070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apolipoprotein E protects cultured pericytes and astrocytes from D-Abeta(1-40)-mediated cell death.
    Bruinsma IB; Wilhelmus MM; Kox M; Veerhuis R; de Waal RM; Verbeek MM
    Brain Res; 2010 Feb; 1315():169-80. PubMed ID: 20034483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer's disease.
    Gomez-Isla T; West HL; Rebeck GW; Harr SD; Growdon JH; Locascio JJ; Perls TT; Lipsitz LA; Hyman BT
    Ann Neurol; 1996 Jan; 39(1):62-70. PubMed ID: 8572669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apolipoprotein E modulates Alzheimer's Abeta(1-42)-induced oxidative damage to synaptosomes in an allele-specific manner.
    Lauderback CM; Kanski J; Hackett JM; Maeda N; Kindy MS; Butterfield DA
    Brain Res; 2002 Jan; 924(1):90-7. PubMed ID: 11743999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebral beta-amyloid deposition is augmented by the -491AA promoter polymorphism in non-demented elderly individuals bearing the apolipoprotein E epsilon4 allele.
    Pahnke J; Walker LC; Schroeder E; Vogelgesang S; Stausske D; Walther R; Warzok RW
    Acta Neuropathol; 2003 Jan; 105(1):25-9. PubMed ID: 12471457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Little evidence of reduced survival to adulthood of apoE epsilon4 homozygotes in Down's syndrome.
    Edland SD; Wijsman EM; Schoder-Ehri GL; Leverenz JB
    Neuroreport; 1997 Nov; 8(16):3463-5. PubMed ID: 9427308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
    Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
    Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apolipoprotein E modulates gamma-secretase cleavage of the amyloid precursor protein.
    Irizarry MC; Deng A; Lleo A; Berezovska O; Von Arnim CA; Martin-Rehrmann M; Manelli A; LaDu MJ; Hyman BT; Rebeck GW
    J Neurochem; 2004 Sep; 90(5):1132-43. PubMed ID: 15312168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease.
    Bales KR; Verina T; Cummins DJ; Du Y; Dodel RC; Saura J; Fishman CE; DeLong CA; Piccardo P; Petegnief V; Ghetti B; Paul SM
    Proc Natl Acad Sci U S A; 1999 Dec; 96(26):15233-8. PubMed ID: 10611368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebral amyloid angiopathy-related hemorrhage in a middle-aged patient with Down's syndrome.
    Naito KS; Sekijima Y; Ikeda S
    Amyloid; 2008 Dec; 15(4):275-7. PubMed ID: 19065301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A quartet of Down's syndrome, Alzheimer's disease, cerebral amyloid angiopathy, and cerebral haemorrhage: interacting genetic risk factors.
    McCarron MO; Nicoll JA; Graham DI
    J Neurol Neurosurg Psychiatry; 1998 Sep; 65(3):405-6. PubMed ID: 9728967
    [No Abstract]   [Full Text] [Related]  

  • 40. Apolipoprotein E epsilon 2 allele promotes longevity and protects patients with Down's syndrome from dementia.
    Royston MC; Mann D; Pickering-Brown S; Owen F; Perry R; Raghavan R; Khin-Nu C; Tyrer S; Day K; Crook R
    Neuroreport; 1994 Dec; 5(18):2583-5. PubMed ID: 7696609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.